ALTERNATIVE CELLULAR THERAPEUTICS
Alternative Cellular Therapeutics is an organization primarily operates in the Biological Products, except Diagnostic business / industry within the Chemicals and Allied Products sector.
ALTERNATIVE CELLULAR THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Address:
Marietta, Georgia, United States
Country:
United States
Status:
Active
Similar Organizations
Biomedical Consultant Group
Biomedical Consultant Group primarily operates in the Biological Research business.
Cyan Bio
Cyan Bio operates in the Biological Products.
Mperia Therapeutics
Mperia Therapeutics is a biotechnology company.
More informations about "Alternative Cellular Therapeutics"
Home - Last Chance Treatment Foundation
The treatments provided by Last Chance Treatment Foundation will be principally relying upon alternative cellular treatments, Regenerative Medicine Therapy, Hyperbaric Oxygen Chamber, and other revolutionary modalities for dealing โฆSee details»
Alternative Cellular Therapeutics - Crunchbase
Alternative Cellular Therapeutics operates in the Biological Products. Alternative Cellular Therapeutics is an organization primarily operates in the Biological Products, except โฆSee details»
Alternative Cellular Therapeutics LLC - Drug pipelines, Patents ...
Last update 01 Nov 2024. Alternative Cellular Therapeutics LLC. Private Company |See details»
Alternative Cellular Therapeutics | IT History Society
Alternative Cellular Therapeutics operates in the Biological Products.Alternative Cellular Therapeutics is an organization primarily operates in the Biological Products, except โฆSee details»
Government development of โmade-in-Canadaโ CAR-T โฆ
Oct 3, 2024 Summary: Chimeric Antigen Receptor T, or CAR-T cell immunotherapy, is a novel treatment that genetically engineers a patientโs own T-cells to recognize and attack cancer cells. CAR-T therapeutics have been โฆSee details»
Facts About Cellular Therapies - AABB
Cellular therapy (CT) is the transplantation of human cells to replace or repair damaged tissue and/or cells. With new technologies, innovative products, and limitless imagination, many โฆSee details»
Alternative Cellular Therapeutics - Crunchbase
Alternative Cellular Therapeutics operates in the Biological Products.See details»
Home Page: Transplantation and Cellular Therapy, โฆ
Jul 5, 2024 Transplantation and Cellular Therapy, the official publication of the American Society for Transplantation and Cellular Therapy, focuses on current technology and knowledge in the interdisciplinary field of hematopoetic stem โฆSee details»
Adoptive Cell Transfer and Vaccines in Melanoma: The โฆ
May 13, 2022 The major classes of alternative cellular therapy strategies, aside from TIL, include transgenic T-cell receptor (TCR) therapy, chimeric antigen receptor therapy, and natural killer cell therapy. These strategies involve โฆSee details»
ASTCT Home
The American Society for Transplantation and Cellular Therapy is an international professional membership association of more than 3,900 physicians, investigators and other health care professionals from more than 50 countries. Our mission โฆSee details»
CAR-T & Beyond: CGTs In Development In 2022 - Cell โฆ
Sep 8, 2022 <p data-pm-slice="1 1 []">There's more going on in cell and gene therapy work than CAR-T. This article reviews the main cell technologies currently being developed in clinical research, including examples of studies โฆSee details»
Proceedings of the 2nd Meeting of the Asian Cellular Therapy โฆ
Nov 30, 2011 Proceedings of the 2nd Meeting of the Asian Cellular Therapy Organization. ... Haploidenticalfamily donor is an alternative for whom indicated for allogeneic hematopoietic โฆSee details»
Adoptive Cellular Transfer Immunotherapies for Cancer
Jan 1, 2022 According to World Health Organization, cancer is the second leading cause of death worldwide, counting annually about 10 million deaths. In 2020, the most common new โฆSee details»
The activities and regulatory landscape of cellular therapies
In Australia, human cell and tissue therapy products are classified as biologicals and CAR T-cells are classified as Class 4 biologicals (high-risk products) that are more than minimally โฆSee details»
Acellular Biomaterials: An Evolving Alternative to Cell-Based โฆ
Mar 13, 2013 Acellular biomaterials have emerged as an alternative to cell therapy for treating these damaged tissues . Traditional acellular biomaterials (e.g., metal and plastic joint โฆSee details»
First Analysis invests in Applied StemCell, a leading cell and gene ...
Jul 16, 2024 Developer of a proprietary research-to-production gene editing and induced-stem-cell platform to advance cell and gene therapy. CHICAGO โ July 16, 2024 โ First Analysis, a โฆSee details»
Beyond CAR T cells: exploring alternative cell sources for CAR-like ...
May 21, 2024 Chimeric antigen receptor (CAR)-T cell therapy has led to remarkable clinical outcomes in the treatment of hematological malignancies. However, challenges remain, such โฆSee details»
Challenges and new technologies in adoptive cell therapy
Aug 18, 2023 Despite these advances, CAR-T cell therapy still has limitations in both autologous and allogeneic settings, including practicality and toxicity issues. To overcome these โฆSee details»
Arcellx, Inc.: Trying To Build A Better Myeloma Cell Therapy
2 days ago Granted, cell therapy companies have shown historically that there is upside in bringing something new to the table, as ACLX's own partner Kite was purchased back in 2017 โฆSee details»
ASGCT (American Society of Gene and Cell Therapy) 2025 - TFS ...
Join us at ASGCT (American Society of Gene and Cell Therapy) 2025, happening May 13-17 in New Orleans, Louisiana! Meet TFSโs experienced CRO team and explore our specialized โฆSee details»